Indivior Pharmaceuticals (INDV) Share-based Compensation (2024 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Share-based Compensation of $9.0 million for Q1 2026, up 200.0% year-over-year from $3.0 million in Q1 2025, and down 60.87% quarter-over-quarter from $23.0 million in Q4 2025.
Indivior Pharmaceuticals (INDV) Share-based Compensation (2024 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Share-based Compensation history runs 3 years deep, the most recent figure standing at $9.0 million for Q1 2026.
- In Q1 2026, Share-based Compensation rose 200.0% year-over-year to $9.0 million; the TTM figure through Mar 2026 stood at $32.0 million (up 540.0% YoY), while the FY2025 annual figure was $26.0 million, up 18.18% from the prior year.
- Share-based Compensation for Q1 2026 stood at $9.0 million, down from $23.0 million in the prior quarter.
- The five-year high for Share-based Compensation was $23.0 million in Q4 2025, with the low at -$8.0 million in Q2 2024.
- The 3-year median for Share-based Compensation is $8.0 million (2024), against an average of $8.1 million.
- Peak annual rise in Share-based Compensation reached 1050.0% in 2025, while the deepest fall reached 85.0% in 2025.
- Indivior Pharmaceuticals' Share-based Compensation stood at $2.0 million in 2024, then surged by 1050.0% to $23.0 million in 2025, then plunged by 60.87% to $9.0 million in 2026.
- Business Quant data shows INDV's Share-based Compensation at $9.0 million in Q1 2026, $23.0 million in Q4 2025, and $3.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Indivior Pharmaceuticals | 4.51 Bn | 4.29 Bn | 294.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.00 Mn |
| Mar 31, 2026 | 9.00 Mn |
| Dec 31, 2025 | 23.00 Mn |
| Dec 31, 2025 | 23.00 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Dec 31, 2024 | 2.00 Mn |
| Dec 31, 2024 | 2.00 Mn |
| Sep 30, 2024 | 8.00 Mn |
| Sep 30, 2024 | 8.00 Mn |
| Jun 30, 2024 | -8.00 Mn |
| Jun 30, 2024 | -8.00 Mn |
| Mar 31, 2024 | 20.00 Mn |
| Mar 31, 2024 | 20.00 Mn |